Table 3.
Taxane | S-1 | |
---|---|---|
Least square means [95 % CI] | ||
(a) During survival | ||
Up to 60 months | 0.741 [0.713–0.769] | 0.748 [0.722–0.775] |
Up to 36 months | 0.750 [0.728–0.772] | 0.776 [0.756–0.796] |
(b) During progression-free stage | ||
Up to 36 months | 0.781 [0.754–0.809] | 0.811 [0.781–0.841] |
Up to 12 months | 0.772 [0.751–0.792] | 0.812 [0.789–0.834] |
(c) After progression | ||
Up to 36 months | 0.721 [0.698–0744] | |
(d) Before death | ||
0–6 months before | 0.621 [0.584–0.657] | |
6–12 months before | 0.713 [0.688–0.738] |